Literature DB >> 22894674

COL10A1 expression is elevated in diverse solid tumor types and is associated with tumor vasculature.

Karen B Chapman1, Maria J Prendes, Hal Sternberg, Jennifer L Kidd, Walter D Funk, Joseph Wagner, Michael D West.   

Abstract

AIM: The identification of molecular markers that are upregulated in multiple tumor types could lead to novel diagnostic and therapeutic strategies. The authors screened a panel of RNAs prepared from diverse tumors and tumor cell lines, and compared them with normal tissues and cultured somatic cell types, in order to identify candidate genes expressed in a broad spectrum of tumor types. MATERIALS &
METHODS: Gene expression microarray analysis was carried out on 128 individual tumor samples representing over 20 tumor types, 85 samples representing 31 diverse normal tissue types, 68 tumor cell lines and 97 diverse normal primary cell cultures. Genes were ranked for elevated expression across a large number and variety of tumors relative to normal tissues. RESULTS &
CONCLUSION: COL10A1 was identified as a gene with restricted expression in most normal tissues and elevated expression in many diverse tumor types. By contrast, COL10A1 expression was undetectable in the 68 tumor cell lines surveyed in this study. Immunofluorescence studies localized collagen, type X, α-1 (collagen X) staining to tumor vasculature in breast tumors, whereas the vasculature of normal breast tissue was either collagen X-negative or had markedly lower levels. The tumor microenvironment-specific expression of collagen X, together with its localization in the vasculature, may facilitate its use as a novel target for the diagnosis and treatment of diverse solid tumor types.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22894674     DOI: 10.2217/fon.12.79

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  28 in total

1.  Determination of whole transcription profiles and specific pathways in invasive ductal breast carcinoma.

Authors:  Pasra Arnutti; Manas Kotepui; Wichitra Asanprakit; Phaibul Punyarit; Porntip Chavalitshewinkoon-Petmitr; Talabporn Harnroongroj; Songsak Petmitr
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

2.  Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.

Authors:  Shuai Chen; Yi Wei; Hanyang Liu; Yu Gong; Yan Zhou; Haojun Yang; Liming Tang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.

Authors:  Yuriko Uehara; Katsutoshi Oda; Yuji Ikeda; Takahiro Koso; Shingo Tsuji; Shogo Yamamoto; Kayo Asada; Kenbun Sone; Reiko Kurikawa; Chinami Makii; Otoe Hagiwara; Michihiro Tanikawa; Daichi Maeda; Kosei Hasegawa; Shunsuke Nakagawa; Osamu Wada-Hiraike; Kei Kawana; Masashi Fukayama; Keiichi Fujiwara; Tetsu Yano; Yutaka Osuga; Tomoyuki Fujii; Hiroyuki Aburatani
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

4.  BioXpress: an integrated RNA-seq-derived gene expression database for pan-cancer analysis.

Authors:  Quan Wan; Hayley Dingerdissen; Yu Fan; Naila Gulzar; Yang Pan; Tsung-Jung Wu; Cheng Yan; Haichen Zhang; Raja Mazumder
Journal:  Database (Oxford)       Date:  2015-03-28       Impact factor: 3.451

5.  Gene expression profiling of breast cancer in Lebanese women.

Authors:  Joelle Makoukji; Nadine J Makhoul; Maya Khalil; Sally El-Sitt; Ehab Saad Aldin; Mark Jabbour; Fouad Boulos; Emanuela Gadaleta; Ajanthah Sangaralingam; Claude Chelala; Rose-Mary Boustany; Arafat Tfayli
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

6.  Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference Transcriptomes.

Authors:  Yang Liu; Xiaoyao Yin; Jing Zhong; Naiyang Guan; Zhigang Luo; Lishan Min; Xing Yao; Xiaochen Bo; Licheng Dai; Hui Bai
Journal:  Genes (Basel)       Date:  2017-02-24       Impact factor: 4.096

7.  High expression of COL10A1 is associated with poor prognosis in colorectal cancer.

Authors:  Haipeng Huang; Tingting Li; Gengtai Ye; Liying Zhao; Zhenzhan Zhang; Debin Mo; Yiming Wang; Ce Zhang; Haijun Deng; Guoxin Li; Hao Liu
Journal:  Onco Targets Ther       Date:  2018-03-20       Impact factor: 4.147

8.  Discovery and validation of new potential biomarkers for early detection of colon cancer.

Authors:  Xavier Solé; Marta Crous-Bou; David Cordero; David Olivares; Elisabet Guinó; Rebeca Sanz-Pamplona; Francisco Rodriguez-Moranta; Xavier Sanjuan; Javier de Oca; Ramon Salazar; Victor Moreno
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

9.  Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer.

Authors:  Alexander S Brodsky; Jinjun Xiong; Dongfang Yang; Christoph Schorl; Mary Anne Fenton; Theresa A Graves; William M Sikov; Murray B Resnick; Yihong Wang
Journal:  BMC Cancer       Date:  2016-04-18       Impact factor: 4.430

10.  Risk score based on three mRNA expression predicts the survival of bladder cancer.

Authors:  Qingzuo Liu; Ruigang Diao; Guoyan Feng; Xiaodong Mu; Aiqun Li
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.